Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model

por Taskin, Banu, Erdoğan, Mümin Alper, Yiğittürk, Gürkan, Günenç, Damla, Erbaş, Oytun
Publicado 2017

PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment

por Gürsoy, Pınar, Çakar, Burcu, Günenç, Damla, Nart, Deniz, Çinkooğlu, Akın, Katgı, Nuran
Publicado 2022

Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs

por Zhang, Tian, Forde, Patrick M, Sullivan, Ryan J, Sharon, Elad, Barksdale, Elizabeth, Selig, Wendy, Ebbinghaus, Scot, Fusaro, Gina, Gunenc, Damla, Battle, Dena, Burns, Robyn, Hurlbert, Marc S, Stewart, Mark, Atkins, Michael B
Publicado 2023

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study

por Yıldırım, Hasan Çağrı, Mutlu, Emel, Chalabiyev, Elvin, Özen, Miraç, Keskinkılıç, Merve, Ön, Sercan, Çelebi, Abdussamet, Dursun, Bengü, Acar, Ömer, Kahraman, Seda, Aykan, Musa Barış, Kaman, Ömür, Doğan, Akif, Erdoğan, Atike Pınar, Melisa Celayir, Özde, Günenç, Damla, Güven, Deniz Can, Vedat Bayoğlu, İbrahim, Yavuzşen, Tuğba, Hacıbekiroğlu, İlhan, İnanç, Mevlüde, Kılıçkap, Saadettin, Yalçın, Şuayib, Aksoy, Sercan
Publicado 2022